Cannabis Consumption Research Articles

Unveiling wine and cannabis consumption motivations: a segmentation study of wine consumers in Germany

Purpose Wine consumption is declining, while cannabis use among young adults in Germany has surged. With new laws partially legalising recreational cannabis, advocates claim it could replace alcohol, offering health benefits and cost savings. However, concerns remain that cannabis might increase alcohol consumption and associated health risks. Despite recognition of both substitute and complementary relationships between cannabis and alcohol, data on the cannabis–wine relationship is scarce. This study aims to understand the motivations behind wine and cannabis consumption, segment wine drinkers by those motives, profile wine drinkers who also consume cannabis and determine whether wine and cannabis act as substitutes or complements across distinct consumer groups. Design/methodology/approach The authors conducted an online survey using random sampling and used cluster analysis to identify consumer segments based on motivations for wine consumption. Exploring various variables, including consumption motives, behavioural patterns and socio-demographics, the authors also examined cannabis consumption among wine drinkers. Findings This study surveyed 523 German wine drinkers aged 20–60 years, including 215 cannabis users. Four consumer segments emerged: “adaptive conformists”, “expansive strategists”, “self-conscious hedonists” and “ambivalent drinkers.” Three segments preferred wine for social and enhancing effects. “Adaptive conformists”, the group with the most cannabis users, sought negative reinforcement like conformity or coping. The “adaptive conformists” and “expansive strategists” show the tendencies of a complementary cannabis–wine relationship. Originality/value This study pioneers the use of the Marijuana Motives Measure scales, developed by Simons et al. (1998), within the motivational framework by Cox and Klinger (1988) and Cooper et al. (2015), for wine drinkers. To the best of the authors’ knowledge, this is also the first to categorise wine drinkers into segments based on MMM scales for both wine and cannabis and segment wine consumers using cannabis.

The relationship between cannabis and cardiovascular disease: clearing the haze.

Cannabis has been consumed for centuries, but global regulatory changes over the past three decades have increased the availability and consumption of cannabis. Cannabinoids are touted to have therapeutic potential for many diseases and could be a replacement for opioids for analgesia and sedation. However, cannabinoids can cause substantial adverse cardiovascular events that would mitigate any potential benefit. The endocannabinoid system regulates mood, satiety and memory, and modulates the cardiovascular system. The link between cannabinoids and cardiovascular disease, which used to be limited to evidence from preclinical studies, case reports and case series, is now evident in epidemiological studies. Cannabinoids adversely affect the cardiovascular system, causing myocardial infarction, cerebrovascular accidents, arrhythmia and heart failure. The effects of novel cannabinoids are unknown, and synthetic cannabinoids have the potential to cause even more substantial harm than traditional cannabinoids. Therefore, with the increasing availability and use of cannabis, the acute and chronic effects of this drug are becoming apparent.

“Becoming a Medical Cannabis User” Revisited: Understanding the Role of Low-Threshold Access Points in British Columbia, Canada

The work of sociologist Howard Becker has been used extensively to study and theorize the experience of using cannabis for recreational purposes and more recently, the experience of using cannabis for medical purposes. Building on recent research that uses Becker's work to study and theorize the process of becoming a medical cannabis use r, we extracted and analyzed interview data from a larger qualitative case study of low-threshold access points (i.e., medical dispensaries and cannabis clubs) in British Columbia (Canada). The majority of participants were 50 years or older, had an annual income of less than $30,000, listed disability assistance as their primary source of income, and were renting a room or an apartment. Educational level was distributed across the sample and gender representation was close to balanced with seven cisgender women and five cisgender men. All of the participants identified as White (European descent). In terms of cannabis consumption, the majority of participants reported using daily and indicated a preference for ingesting cannabis, followed by smoking and applying topically. Our theory-informed analysis suggests that becoming a medical cannabis user is a process that requires low-threshold access to community, medicine, and space—three domains across which learning unfolds, in relationships (with staff and peers) and in response to health and social needs. Our analysis also points to three categories of learning: learning about medical cannabis, learning to medicate, and learning to substitute. Overall, our findings indicate that learning across all three categories and low-threshold access to community, medicine, and space go hand in hand in the process of becoming a medical cannabis user—thus generating new theoretical insights and empirical avenues. The findings also raise important questions about the closure of low-threshold access points in British Columbia and the impact of cannabis legalization more generally.

Oral lesions and disorders and their prevalence arising from the use of illicit drugs in a prison population.

The dependence on the illicit drugs has been proven to be harmful to the oral cavity and may lead to a series of abnormal manifestations. The main objective of this study was to observe the effects caused by the consumption of illicit drugs in the oral cavity, in a prison population in the North of Portugal. A cross-sectional observational study was conducted involving 91 male inmates aged 25-75 years (mean age 41.14 ± 8.98), from Paços de Ferreira Prison. The participants were subjected to a medical interview and a clinical examination. Descriptive statistics and the Chi-square test were used to assess the association between the qualitative variables. The level of statistical significance used was α ≤ 0.05. The consumption of illicit drugs proved to be a common practice (86.8%), where cannabis, heroin and cocaine were the most prevalent (29.1%). Thirty-one inmates were attending the methadone rehabilitation program (34.1%). Most of patients consuming illicit substances, were also smokers (93.7%) (p<.001). Of the 91 participants, 82 (90.1%) presented oral manifestations, with caries lesions being the most prevalent (61.0%) and oral mucosa lesions the least observed (3.7%). Heavy drug consumption was related with rampant caries lesion (p=.011) and chewing difficulty (p=.024) when compared with cannabis consumption. The main oral manifestations found, associated to the consumption of illicit drugs were caries lesions, tooth loss and sensitivity, periodontal diseases, temporomandibular disorders, xerostomia, and bruxism.

Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States.

Some cannabis consumption methods (e.g. smoking, vaping, dabbing) are associated with more harms than others (e.g. sublingual, transdermal). We aimed to examine differences in prevalence of cannabis consumption methods by people with medically recommended-only vs. nonmedical-only cannabis use. Cross-sectional, US nationally representative data from the 2022 National Survey on Drug Use and Health (NSDUH). 14 271 NSDUH participants aged ≥12 with past-year cannabis use. NSDUH asked respondents with past-year cannabis use about their consumption methods [i.e. smoking, vaping, eating or drinking, dabbing (consuming a concentrated form with a dab rig/pen), oral/sublingual, transdermal or taking pills] and if healthcare professionals recommended any cannabis use. If 'no', respondents were classified as having 'nonmedical-only cannabis use'. If 'yes', they were asked if all cannabis use was recommended and, if so, they were classified as having 'medically recommended-only cannabis use'; otherwise, they were classified as having 'medical and nonmedical cannabis use'. Among people reporting cannabis use, 10.7% [95% confidence interval (CI) = 9.7%-11.7%] reported medically recommended-only use, and 83.0% (95% CI = 81.7%-84.3%) reported nonmedical-only use. Smoking was the predominant method for nonmedical-only use (79.2%, 95% CI = 77.7%-80.7%) and for medically recommended-only use (73.7%, 95% CI = 68.8%-78.2%). Vaping prevalence (45.6%, 95% CI = 40.9%-50.4%) and eating/drinking prevalence (45.7%, 95% CI = 40.7%-50.7%) were similar among people with medically recommended-only use. Vaping prevalence was 1.3 times higher [adjusted prevalence ratio (APR) = 1.3, 95% CI = 1.2-1.4] for medically recommended-only than for nonmedical-only use (38.3%, 95% CI = 32.7%-44.3%). Dabbing prevalence was 1.5 times higher (APR = 1.5, 95% CI = 1.3-1.7) for medically recommended-only than for nonmedical-only use [24.4% (95% CI = 20.5%-28.8%) vs 16.4% (95% CI = 15.3%-17.7%)]. Higher prevalence of oral/sublingual and transdermal methods was associated with medically recommended-only use. Among people with past-year medically recommended-only cannabis use in the US, three-fourths reported smoking cannabis and almost half reported vaping and eating/drinking cannabis. Cannabis vaping prevalence and dabbing prevalence were 1.3-1.5 times higher, respectively, among people with medically recommended-only use than people with nonmedical-only use.

Manufacturing the Entheogenic Underground

Ethnographic research suggests that people across the United States are increasingly gathering to commune with their creators, to interact with their ancestors, to enter the spirit world, to gain supernatural insights, and to engage in what they otherwise describe as religious or spiritual experiences. In this regard, their actions are not particularly revolutionary or novel. What distinguishes these people is not their desire to have religious or spiritual experiences. Instead, it is the means they employ to occasion these experiences that set them apart, as their rituals and ceremonies involve the consumption of illegal drugs, specifically psychedelics and cannabis, substances they frequently term entheogens. The United States government has granted select groups an exemption from drug prohibition, thereby allowing them to legally consume what are otherwise illegal substances. The vast majority of these practitioners, however, operate without this exemption, thereby confining them to what scholars often term the underground, or the sociocultural, political, or economic spaces thought to operate outside the influence or purview of the state.4 This alleged “absence” of the government is the topic of this paper, which argues that the state is both the primary curator of the so-called underground and that the state’s influence pervades these “underground” communities. To demonstrate this, this essay will discuss the legal structures and case law impacting entheogenic churches in the United States, paying particular attention to the attorneys who advise these churches.

Substitution and Complementarity in the Consumption of Alcohol, Cannabis, and Opium.

Understanding the behavior of populations of drug consumers has been and remains a topic of keen interest. Using a unique dataset on 25 districts from Bengal, India, from 1911 to 1925, we analyze whether populations of consumers treat alcohol, cannabis, and opium as economic substitutes or complements in a legal regime. Additionally, we examine responsiveness to prices and income. Our analysis has three main findings. First, we find evidence of substitution between alcohol and cannabis bud. Second, cannabis leaf is a complement for alcohol but a substitute for cannabis bud. Third, we find negative income elasticity for alcohol, cannabis bud, and opium consumption. These findings on the link between consumption patterns and economic factors can guide harm reduction strategies.

Cannabis vaping elicits transcriptomic and metabolomic changes in inflammatory, oxidative stress and cancer pathways in human bronchial epithelial cells.

The increasing shift from cannabis smoking to cannabis vaping is largely driven by the perception that vaping to form an aerosol represents a safer alternative to smoking and is a form of consumption appealing to youth. Herein, we compared the chemical composition and receptor-mediated activity of cannabis smoke extract (CaSE) to cannabis vaping extract (CaVE) along with the biological response in human bronchial epithelial cells. Chemical analysis using HPLC and GC/MS revealed that cannabis vaping aerosol contained fewer toxicants than smoke; CaSE and CaVE contained teratogens, carcinogens, and respiratory toxicants. A bioluminescence resonance energy transfer (BRET)-based biosensor detected the receptor-mediated activity of the extracts, primarily driven by Δ9-THC concentration. RNA- sequencing showed both CaSE and CaVE induced similar transcriptional responses, significantly upregulating genes within pathways related to inflammation, cancer, and cellular stress. This was paralleled by downregulation of pathways related to lipid synthesis and metabolism similarly from both CaSE and CaVE. Targeted metabolomics revealed significant changes in metabolites involved in lipid and membrane metabolism, energy production, nucleotide/DNA/RNA pathways, and oxidative stress response, suggesting potential impairment of lung epithelial cell repair and function. Additionally, the upregulation of 5-hydroxymethylcytosine (5hmC) indicates epigenetic changes potentially contributing to inflammation, oxidative stress, and an increased risk of cancer. These findings challenge the notion that cannabis vaping is risk-free, highlighting an urgent need for comprehensive research into its respiratory health effects. This comparison of cannabis consumption methods offers insights that could inform public health policies and raise consumer awareness regarding the potential risks of inhaling cannabis aerosol.

A systematic review on risk factors and reasons for e-cigarette use in adolescents.

The aim was to establish EC use risk and protective factors, the reasons for use, associations with tobacco and other substance use, and use for smoking cessation. A systematic review following PRISMA guidelines was registered in PROSPERO (CRD42024532771). Searches in Web of Science and PubMed/MEDLINE (March-April 2024) used terms like 'electronic cigarette' and 'adolescents' with a PICO framework. Inclusion criteria covered studies on adolescents aged 10-19 years, published in English or Spanish (2018-2024). Three reviewers independently screened studies, achieving 96% inter-rater reliability. Data extraction followed standardized tables, and methodological quality was assessed using MMAT and GRADE tools, ensuring a robust evaluation of evidence on adolescent electronic cigarette use. From 895 studies, 50 met the inclusion criteria. The strongest risk factors for adolescent EC use include social acceptance and use within peer or family circles (13 studies), male gender (10 studies), low risk perception (6 studies), younger age (3 studies), and greater financial resources (3 studies). Motives for use include low perceived risk and appealing flavors, supported by both longitudinal and cross-sectional studies. EC use is significantly associated with smoking initiation (7 studies), cannabis consumption (8 studies), and alcohol use (4 studies). Evidence on the effectiveness of ECs as harm reduction or smoking cessation tools in adolescents remains inconclusive, with some cross-sectional studies supporting their utility and others finding contrary evidence. High-quality research indicates ECs are predominantly used alongside traditional cigarettes, with dual nicotine consumption patterns commonly observed. Evidence on adolescent EC use identifies risk factors, motives, and links to substance use. However, its role in harm reduction and smoking cessation remains insufficient and controversial. High-quality research is needed, as most studies are low quality. Targeted prevention strategies addressing social influences, perceptions, and accessibility are crucial to reduce adolescent EC use.

Fine and Ultrafine Particle Concentrations in a Cannabis Consumption Lounge

Fine and Ultrafine Particle Concentrations in a Cannabis Consumption Lounge

Descriptive norms for simultaneous cannabis and alcohol use predict simultaneous use patterns assessed via daily surveys.

Simultaneous cannabis and alcohol use is common, but few studies have examined normative perceptions of simultaneous use. This study examined unique associations of baseline descriptive norms for simultaneous use (i.e., perceptions about others' simultaneous use) with simultaneous use behaviors assessed via daily surveys. Young adults reporting frequent simultaneous use (N = 150) completed baseline measures of descriptive norms for the frequency of simultaneous use and the amounts of cannabis and alcohol consumed during typical simultaneous use occasions. Further, participants completed measures of descriptive norms for the frequency and quantity of cannabis and alcohol use in general (not limited to simultaneous use). Norms were assessed referencing both peer and friend groups. Following this assessment, participants completed 21 daily smartphone surveys assessing cannabis and alcohol use each day. Simultaneous use was operationalized as same-day use of cannabis and alcohol. Multilevel models revealed that, controlling for descriptive norms for cannabis and alcohol use in general, perceiving more frequent simultaneous use among friends (but not peers) was significantly associated with a greater tendency to engage in simultaneous use relative to cannabis-only use across days. Further, perceiving heavier cannabis and alcohol consumption during simultaneous use occasions among friends (but not peers) was significantly associated with greater quantities of cannabis and alcohol consumed, respectively, across simultaneous use days. Descriptive norms for simultaneous use contribute uniquely to simultaneous use behavior, over and above norms for cannabis use and alcohol use in general. Findings may inform norms-based interventions for young adults who engage in simultaneous use. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

Cannabis use and atherosclerotic cardiovascular disease outcomes: A meta-analysis of multinational cohort data.

While an association between cannabis use and the risk of atherosclerotic cardiovascular diseases (ASCVD) has been reported numerous times, it remains inconclusive as to whether this link is causal in nature. We sought to consolidate data from observational studies to explore the association between ever use of cannabis and ASCVD outcomes, including myocardial infarction, stroke, and a combined measure of any adverse cardiovascular events in comparison to non-users or controls. We performed a systematic literature search on PubMed, Scopus, ScienceDirect, and Cochrane Library for relevant studies from inception until April 2024. Statistical analyses utilized RevMan 5.4 with a random effects model. The study protocol has been registered with PROSPERO (CRD42024530366). Our analysis incorporated data from 17 studies involving a total of 1,902,481 individuals aged between 18 and 74 years, with a mean follow-up duration of 8.5 years. Upon pooled analysis, no statistically significant association was found between cannabis use and the risk of myocardial infarction compared to non-users, with an RR of 1.25 (95% CI: 0.91-1.71, p = 0.17). Similarly, while the risk of stroke showed no significant association with cannabis use (RR: 1.38, 95% CI: 0.88 to 2.16, p = 0.16), a statistically significant association was observed between ever use of cannabis and the composite of any adverse cardiovascular events (RR: 1.48, 95% CI: 1.16-1.90, p = 0.002). The evident statistical correlations between cannabis use and adverse cardiovascular outcomes underscore its potential as a risk factor for cardiovascular disease, suggesting plausibility for a causal relationship between cannabis use and ASCVD. With rising trends in medical cannabis use and cannabis use disorder across age demographics, heightened risk awareness and informed decision-making regarding cannabis consumption are critical priorities in healthcare and public health initiatives.

Divergence in Cannabis and Alcohol Use Disorder Prevalence Trends from 2002-2019

IntroductionDespite increases in availability, potency, and consumption of cannabis, epidemiological data suggest decreases in prevalence of cannabis use disorder (CUD) in some groups. Understanding mechanisms for these changes may help improve diagnostic tools for identifying disordered use. This analysis evaluates changes in CUD compared to a substance with comparably stable social and environmental context (alcohol use disorder [AUD]) as well as treatment engagement and need from 2002 to 2019. MethodsData were from the National Survey on Drug Use and Health. Outcomes included CUD and AUD symptoms, treatment engagement, and perceived need. Temporal trends and average annual rate of change [AARC] were computed. ResultsBetween 2002 and 2019, daily cannabis use prevalence increased by 94% (AARC=11.68%), whereas CUD prevalence among those using cannabis daily reduced by 47.9% (AARC=-10.30%). Daily alcohol use prevalence decreased by 10.86% (AARC=-1.90%), and AUD prevalence among those using alcohol daily reduced by 3.9% (AARC=-0.67%). Prevalence of individual 12-month CUD criteria among those using cannabis daily decreased (-13.4 to -59.6% change; AARC = -2.4% to -14%). Among those using cannabis daily, trends in prevalence of individual AUD criteria varied, with some criteria increasing in prevalence and others decreasing (-30.2% to 24.6% change; AARC = -5.82% to 3.7%). Treatment engagement and perceived need reduced for cannabis, whereas treatment engagement increased and perceived need decreased for alcohol. ConclusionThese results suggest that CUD and AUD criteria may be determined within the cultural context dictating the definition of harm which has changed for cannabis, but not alcohol, from 2002-2019.

Bronchial Challenge in the Diagnosis of Cannabis Allergy.

We have read with great interest the recent review published by Dr. Ebo and collaborators on cannabis allergy. It highlights the difficulties in getting a valid diagnosis because some patients do not admit its consumption, which may not be legalized, there are no commercial extracts and there are problems in cutaneous tests interpretation due to cross-reactivity with other related allergens. In addition to this, bronchial challenge is considered the confirmatory diagnosis, but it is complex to perform. This also occurs in diagnosis of occupational asthma, such as in baker's asthma, in which we have investigated a reliable marker to avoid the bronchial challenge. However, we think it is necessary to do this test to ensure a correct etiological diagnosis of cannabis asthma, and we have carried out bronchial challenge with cannabis on more than 600 patients since 2009, all them active consumers. In our country cannabis consumption has not been legalized, but to do this challenges we asked the National Court for permission, which we obtained easily. Although molecular diagnosis has helped in revealing the problems caused by cross-reactivity, the gold standard continues to be the provocation. In our articles we detail how to do it safely, and we encourage our colleagues to reach a definitive diagnosis that cannabis is the cause of their bronchial symptoms.

The impact of using cannabis during pregnancy on the infant and mother: An overview of systematic reviews, evidence map, targeted updates, and de novo synthesis.

Cannabis use during pregnancy is becoming more prevalent. While numerous studies have explored the relationship of cannabis use during pregnancy and outcomes for mothers and infants, uncertainty remains regarding the impact of cannabis use on pregnancy complications and later-life outcomes for offspring. To produce a summary of the short and long-term effects of prenatal cannabis exposure on fetal growth and development, neonatal conditions, later-life, and maternal outcomes. An overview of systematic reviews, an evidence and gap map, targeted updates of previous reviews, and de novo evidence synthesis was conducted. The databases searched include PubMed (National Center for Biotechnology Information); MEDLINE (Ovid); Embase (Ovid) and CINAHL with Full Text (EBSCO). Assessment of risk of bias was conducted in duplicate for all studies. Relevant studies were coded and are presented as an evidence and gap map. Where possible, meta-analyses were conducted with a narrative synthesis of the results. Primary studies and systematic reviews examining the relationship between cannabis consumption in pregnancy and the effect on fetal/child development, antenatal, and obstetric outcomes during pregnancy were eligible for inclusion. There were 89 studies/reviews eligible for inclusion in this review. There was a potentially harmful impact of prenatal cannabis exposure on all fetal growth and development outcomes, some neonatal outcomes, some later-life outcomes, and some maternal outcomes. The evidence regarding other neonatal conditions, later-life, and maternal outcomes was mixed. The evidence suggests cannabis should be avoided during pregnancy.

Problematic school functioning and substance use among Gabonese students: Moderating effect of basic psychological needs frustration

ABSTRACT Many studies have been conducted in Africa on the use of psychoactive substances among high school students. However, few studies have examined the psychological mechanisms underlying this consumption. Grounded in self-determination theory (SDT), the present study explored the moderating role of the frustration of basic psychological needs on the relation between problematic school functioning (i.e. academic, emotional, and behavioral difficulties) and the consumption of alcohol and cannabis. The sample consisted of 367 Gabonese students (54% girls; Mage = 18.25). The results showed two direct links: behavioral difficulties positively predicted alcohol use, while emotional difficulties positively predicted cannabis use. Two moderating effects related to behavioral difficulties were also observed: (1) youths with these difficulties are more likely to drink alcohol when they perceive that their need for autonomy is frustrated, and (2) they are more likely to use cannabis when their need for relatedness is frustrated. The results of this study are discussed within SDT framework. The study’s implications and limitations are also addressed.

Quantitative analysis of cannabinoids and metabolites in oral fluid by volumetric absorptive microsampling combined with UHPLC-HRMS.

With recent evolution of cannabis legalization around the world and multiplication of cannabis derived products, identifying and qualifying cannabis consumption has a proven interest. Although blood, plasma, and urine are common matrices widely used in toxicology laboratories, oral fluid presents specific advantages. In the context of doping tests, addiction consultation or roadside checks, where other matrices are impractical to collect or can be adulterated, oral fluid is a promising matrix that allows a non-invasive, rapid, and monitored self-sampling. However, available devices required a consequent volume of oral fluid,more than 250 µL, sometimes difficult to collect. We present here a fully optimized quantitative method for seven cannabinoids, including four metabolites, in oral fluid, Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol; cannabidiol, 7-hydroxy and 7-carboxycannabidiol; and cannabinol. After self-collection of 20 µL using an accurate and precise volumetric absorptive microsampling device (VAMS®), cannabinoids were derivatized with 2-fluoro-1-methylpyridinium p-toluenesulfonate to increase sensitivity. The successive steps of the proposed method, including biosampling, 1 h sample preparation with derivatization, and acquisition by ultrahigh-performance liquid chromatography coupled to high-resolution mass spectrometry, were fully optimized. A limit of quantification of 0.5 ng/mL (≈10 pg per sampling) was thus targeted, adapted to the legal threshold required by the authorities and to clinical monitoring. Applied to six cannabis consumers, the proposed method made it possible to quantify in 20 µL oral fluid samples, Δ9-tetrahydrocannabinol ranging from 0.5 to 6236 ng/mL, cannabidiol from 0.6 to 190 ng/mL and cannabinol from 0.5 to 118 ng/mL.

Understanding Older Adults' Experiences with Cannabis for Medicinal Purposes: A Mixed Methods Study.

The aim of this study was to explore the perspectives of older medicinal cannabis consumers and those advising them on older Canadians' experiences accessing cannabis and information about it, as well as how stigma may influence their experiences. A concurrent triangulation mixed methods design was used. The design was qualitatively driven and involved conducting semi-structured interviews with older adults and advisors and developing a survey for older adults. We used a Qualitative Descriptive approach for the analysis of qualitative data and descriptive statistics for quantitative survey data. Findings demonstrate that many older adults are accessing information about cannabis for medical purposes from retailers, either because they are reticent to talk to their healthcare professionals or were rebuffed when bringing up the subject. We recommend cannabis education be required for healthcare professionals working with older persons and that future research examines their perspectives on medicinal cannabis and older adults.

Help-seeking behaviours among cannabis consumers in Canada and the United States: Findings from the international cannabis policy study.

Little literature exists on what sources of help individuals utilize for cannabis-related problems. The current study examined the percentage of consumers who sought help to manage cannabis-related problems, such as perceived cannabis use disorder, the most common sources of help sought, and factors associated with help-seeking. Past 12-month cannabis consumers (N = 13,209) completed an online survey from the International Cannabis Policy Study. Past 3-month help-seeking behaviours, respondent's perceived addiction to cannabis, legal status of cannabis in their jurisdiction, and risky behaviours associated with cannabis use was assessed. A minority sought help from any source (9.2 %) with the most likely being a doctor/physician (44.9 %). Help-seekers were most likely to be younger, mixed race (p = .011), more educated, financially stable, male, and higher perceived addiction to cannabis (all contrasts p < .001). In comparison to consumers in Canada and 'legal' US states, respondents in 'illegal' US states were more likely to seek help from family and friends (Canada: AOR = 5.73, 2.21-14.91; US: AOR = 4.76, 2.00-11.11) and less likely to seek help from a doctor/physician (Canada: AOR = 0.46, 0.24-0.90; US: AOR = 0.51, 0.27-0.99). Roughly 1 in 10 cannabis consumers sought help from a range of sources, including a third who are at high risk of problematic use. More informal sources of help, such as seeking help from online sources are frequently used. Future research should examine these frontline sources of help for cannabis consumers.

Cannaboom: Race and Labor in California Cannabis Cultures

Encouraged by state requirements for prepackaging, Black and Latinx producers and distributors of legal cannabis in California have developed novel, symbolically and socially significant forms of marketing. Black and Latinx cannabis industries have developed their own “commodity aesthetics,” using product packaging, live events, and social media to entice buyers with a combination of beautiful sights, smells, textures, signs, and symbols that represent the contradictions of working-class Black and Latinx life in contemporary California. Black and Latinx cannabis popular cultures combine images of freedom and transcendence with depictions of the low wage jobs that many Black and Latinx people work. This is because, rather than an impediment to work, cannabis consumption is a kind of support for or accessory to labor. Many consumers use cannabis to dull the tedium and pain of labor and to sustain them throughout the workday. This essay provides a critical overview of Black and Latinx cannabis marketing in California, and its targeting of working-class consumers of color. While I discuss several examples, my central case study is the successful Black and Latinx cannabis distributor Teds Budz. I draw on interviews, ethnographies of live cannabis events, and visual studies of cannabis packages and social media, arguing that seemingly “escapist” qualities in cannabis culture critically foreground the material limits of the world from which Black and Latinx workers are trying to escape. Cannabis commodity aesthetics, I conclude, promise people of color an exit from the drudgery of work that can also tighten their ties to low wage jobs.